Niva Bupa Health Insurance reported a strong second quarter for FY27, with net profit more than doubling to Rs 135.64 crore from Rs 60.52 crore in the same period last year. Revenue also saw significant growth, reaching Rs 2,412.27 crore. The insurer confirmed it is currently compliant with IRDAI expense management regulations. However, investors should monitor ongoing tax and GST litigation involving Rs 156 crore in contingent liabilities.
Niva Bupa Reports Strong Q2 Growth and Regulatory Compliance
Net Profit: Rs 135.64 crore (up from Rs 60.52 crore in Q2 FY26)
Insurance Revenue: Rs 2,412.27 crore (up from Rs 1,899.07 crore in Q2 FY26)
Reader Takeaway: Strong profit growth signals improved underwriting, but active tax and GST disputes remain critical balance sheet watch points.
What just happened
Niva Bupa Health Insurance has released its financial results for the quarter and half-year ended September 30, 2026. The company reported a significant surge in profitability, with its quarterly net profit reaching Rs 135.64 crore compared to Rs 60.52 crore in the corresponding period of the previous year. Insurance revenue similarly trended upward, climbing to Rs 2,412.27 crore from Rs 1,899.07 crore.
Why this matters
The jump in profitability highlights the company's scaling operations in the health insurance sector. Furthermore, the company has officially addressed regulatory concerns regarding Expenses of Management (EoM). For the quarter ended September 30, 2026, the company recorded an EoM ratio of 34.26%, successfully staying under the IRDAI-mandated limit of 35.98%.
Accounting Update
Starting April 1, 2026, Niva Bupa transitioned to Indian Accounting Standards (Ind AS). The results for the current quarter reflect this shift, with comparative figures from the previous year restated to ensure consistency for investors.
Risks to watch
Shareholders should pay attention to pending legal matters that could impact future capital reserves:
- Income Tax: The company is currently contesting assessment orders for AY 2020-21 through AY 2023-24, which involve a demand of Rs 127.16 crore due to expense disallowances.
- GST Inquiry: The Directorate General of GST Intelligence has issued a show-cause notice for Rs 29.28 crore regarding input tax credits on marketing expenses. The company has already deposited Rs 25.00 crore toward this matter.
What to track next
Investors should look for updates on the resolution of these tax and GST litigations, as they represent significant contingent liabilities. Additionally, continued adherence to EoM limits will be a key indicator of operational stability under the new regulatory framework.